Evidence map›Paper›PMID 31061447›Full record

ArticleScientific reports2019

Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens.

Ethan Leng, Jonathan C Henriksen, Anthony E Rizzardi, Jin Jin, Jung Who Nam, Benjamin M Brassuer, Andrew D Johnson, Nicholas P Reder, Joseph S Koopmeiners, Stephen C Schmechel and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ethan LengDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USA. lengx016@umn.edu.
Jonathan C HenriksenDepartment of Lab Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Anthony E RizzardiDepartment of Lab Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Jin JinDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Jung Who NamDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN, USA.
Benjamin M BrassuerDepartment of Lab Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Andrew D JohnsonDepartment of Lab Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Nicholas P RederDepartment of Pathology, University of Washington, Seattle, WA, USA.
Joseph S KoopmeinersDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Stephen C SchmechelDepartment of Lab Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Gregory J MetzgerDepartment of Radiology, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, MN, USA.

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008244 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1988 to 2024
$13.6M
NMR Imaging and SpectroscopyP41EB015894 · NIBIB · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2017
$8.4M
NRSA Training CoreTL1TR002493 · NCATS · UNIVERSITY OF MINNESOTA · PI FULKERSON, JAYNE ALLYN · 2018 to 2022
$3.1M
Development of an Optimal MRI Platform for Prostate Investigations at 7 TeslaR01CA155268 · NCI · UNIVERSITY OF MINNESOTA · PI METZGER, GREGORY JOHN · 2012 to 2016
$2.0M
NCATS NIH HHS TL1 TR002493NCATS NIH HHS UL1 TR002494NCI NIH HHS R01 CA155268NIBIB NIH HHS P41 EB015894U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32-GM008244
6 · The paper itself

Abstract

Prostate cancer (PCa) is a major cause of cancer death among men. The histopathological examination of post-surgical prostate specimens and manual annotation of PCa not only allow for detailed assessment of disease characteristics and extent, but also supply the ground truth for developing of computer-aided diagnosis (CAD) systems for PCa detection before definitive treatment. As manual cancer annotation is tedious and subjective, there have been a number of publications describing methods for automating the procedure via the analysis of digitized whole-slide images (WSIs). However, these studies have focused only on the analysis of WSIs stained with hematoxylin and eosin (H&E), even though there is additional information that could be obtained from immunohistochemical (IHC) staining. In this work, we propose a framework for automating the annotation of PCa that is based on automated colorimetric analysis of both H&E and IHC WSIs stained with a triple-antibody cocktail against high-molecular weight cytokeratin (HMWCK), p63, and α-methylacyl CoA racemase (AMACR). The analysis outputs were then used to train a regression model to estimate the distribution of cancerous epithelium within slides. The approach yielded an AUC of 0.951, sensitivity of 87.1%, and specificity of 90.7% as compared to slide-level annotations, and generalized well to cancers of all grades.

Indexed as

AdenocarcinomaArea Under CurveBiomarkers, TumorBiopsy, NeedleCohort StudiesColorimetryEosine Yellowish-(YS)HematoxylinHumansImage Interpretation, Computer-AssistedImmunohistochemistryKeratinsMaleNeoplasm StagingProstateProstatic Neoplasmsalpha-methylacyl-CoA racemaseBiomarkers, TumorEosine Yellowish-(YS)HematoxylinKeratinsRacemases and EpimerasesTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID31061447
PMCPMC6502869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.